OPTUM PHARMACY 801, INC. - CUSTOM DOSED CHEMOTHERAPY IV MEDICATIONS FOR THE BALTIMORE VA MEDICAL CENTER.
Key Details
Description
CUSTOM DOSED CHEMOTHERAPY IV MEDICATIONS FOR THE BALTIMORE VA MEDICAL CENTER.
Context & Analysis
On Dec 3, 2025, Department of Veterans Affairs obligated $500,000 to OPTUM PHARMACY 801, INC. for custom dosed chemotherapy iv medications for the baltimore va medical center.. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: competed under sap with 1 offer received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in CHANDLER, AZ. The contract is scheduled through Jun 30, 2030. This award is one of several similar procurements from Department of Veterans Affairs under NAICS 325412 — related awards are listed below.
Contractor Information
Similar Awards
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 NOVEMBER
MCKESSON CORPORATION
$1.4B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 OCTOBER
MCKESSON CORPORATION
$1.2B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 DECEMBER
MCKESSON CORPORATION
$1.1B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JANUARY
MCKESSON CORPORATION
$1.1B
LENALIDOMIDE FOR THE SALISBURY VAMC, CHARLOTTE HCC, AND KERNERSVILLE HCC.
EXELAN PHARMACEUTICALS INC
$5.1M
Stay Updated
Get notified about new opportunities matching your interests.